After exposure to low density lipoprotein (LDL) that had been minimally modified by oxidation (MM-LDL), human endothelial cells (EC) and smooth muscle cells (SMC) cultured separately or together produced 2-to 3-fold more monocyte chemotactic activity than did control cells or cells exposed to freshly isolated LDL. This increase in monocyte chemotactic activity was paralleled by increases in mRNA levels for a monocyte chemotactic protein 1 (MCP-1) that is constitutively produced by the human glioma U-105MG cell line. Antibody that had been prepared against cultured baboon smooth muscle cell chemotactic factor (anti-SMCF) did not inhibit monocyte migration induced by the potent bacterial chemotactic factor f-Met-Leu-Phe. However, anti-SMCF completely inhibited the monocyte chemotactic activity found in the media of U-1O5MG cells, EC, and SMC before and after exposure to MM-LDL. Moreover, monocyte migration into the subendothelial space of a coculture of EC and SMC that had been exposed to MM-LDL was completely inhibited by anti-SMCF. Anti-SMCF specifically immunoprecipitated 10-kDa and 12.5-kDa proteins from EC. Incorporation of [35Slmethi-onine into the immunoprecipitated proteins paralleled the monocyte chemotactic activity found in the medium of MM-LDL stimulated EC and the levels of MCP-1 mRNA found in the EC. We conclude that (g) SMCF is in fact MCP-1 and (it) MCP-1 is induced by MM-LDL.
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An important early event in atherogenesis is an increased recruitment of monocytes into the arterial subendothelium (1) (2) (3) (4) . Previous studies have shown that endothelial cells (EC) (5, 6) and smooth muscle cells (SMC) (7, 8) in culture constitutively produce a chemotactic factor that acts on monocytes but not neutrophils. Graves and colleagues (9) demonstrated that the monocyte chemotactic activity in the supernatants from a number of tumor cell lines was inhibited by an antibody made against baboon smooth muscle cell chemotactic factor (anti-SMCF) (10) . Additionally they demonstrated a strong concordance with immunoprecipitation of a protein with an apparent molecular mass of 14.4 kDa. A human glioma cell line, U-1OSMG, constitutively expresses monocyte chemotactic activity. The protein responsible for this activity has been purified, sequenced, and named monocyte chemotactic protein 1 (MCP-1) (11, 12) . Graves and colleagues did not test their antibody against the chemotactic activity secreted by the U-1O5MG cell line, but based on limited primary sequence data from the baboon smooth muscle chemotactic protein, they concluded that their protein was homologous to MCP-1.
We have recently demonstrated that low density lipoprotein (LDL) that has been minimally modified (MM-LDL) is indistinguishable from native LDL by the LDL receptor, is not recognized by the scavenger receptor, and induces EC to secrete high levels of monocyte chemotactic activity, whereas native LDL does not (13) . We have also shown that MM-LDL induces EC to produce colony-stimulating factors, including monocyte colony-stimulating factor (M-CSF), which has been shown to be a potent monocyte chemoattractant (14) .
In this study we provide further evidence that the baboon SMCF is in fact MCP-1. We also demonstrate that MM-LDL induces MCP-1 and that MCP-1 accounts for virtually all of the chemotactic activity produced by EC and SMC in culture before and after exposure to MM-LDL. Furthermore, we show that MM-LDL stimulates monocyte chemotactic activity in cocultures of EC and SMC and that this induced activity is entirely due to MCP-1.
MATERIALS AND METHODS
Cell Culture. Human aortic EC and SMC at passages 6-9 were cultured in Dulbecco's modified Eagle's medium as described (5, 15) . The coculture system was maintained in Iscove's modified medium as described (15) . The human glioma cell line U-105MG, initiated by J. Ponten and B. Westermark at the University of Uppsala, Uppsala, Sweden (16) , was a generous gift from Y. Gillespie (University of Alabama at Birmingham). These cells were cultured in RPMI 1640 medium as described (17) . MM-LDL was prepared as described (13) Measurement of Chemotaxis. Monocytes were obtained by a modification of the Recalde method (18) . The ability of the medium to initiate monocyte chemotaxis was tested in a neuroprobe chamber (5) . Antibody to baboon SMCF was prepared as described (9) . For antibody inhibition studies the conditioned medium was incubated with antibody for 2 hr at 370C and then centrifuged in a microcentrifuge for 1 min at 8000 x g to remove immune complexes before testing for chemotactic activity. Formyl-Met-Leu-Phe (fMLP) at a concentration of 0.1 AM was used as a reference chemoattractant.
Metabolic Labeling and Immunoprecipitation. Human aortic EC in 60-mm dishes were transferred to medium deficient in methionine, 100-250 ACi (1 Ci = 37 GBq) of [35S]methionine per ml was added, and the cells were incubated for 5 hr. The medium was collected and centrifuged to remove detached cells and debris. Irrelevant antibody (rabbit IgG to human 13-lipoprotein) was added to bind any material that nonspecifically bound IgG; this was then removed by precipitation with protein A-Sepharose. Anti-SMCF was added to the supernatant, the mixture was left overnight at 40C, and bound molecules were precipitated with protein A-Sepharose. The pellet was washed three times with a solution containing 1% Triton X-100 and 1% bovine serum albumin, and proteins were solubilized in sample buffer containing 2% 2-mercaptoethanol, heated at 100'C for 5 min, and electrophoresed on 12% acrylamide gels. Gels were fixed in 10% methanol/5% acetic acid solution overnight, washed in distilled water, soaked in 1 M sodium salicylate/5% glycerol for 30 min, dried, and exposed to Kodak XAR-5 film.
Northern Blot Analysis. Total RNA was isolated from human aortic EC, SMC, and the human glioma U-1O5MG cell line by the guanidinium isothiocyanate method of Chomczynski and Sacchi (19) . The alcohol-precipitated RNA was electrophoresed on formaldehyde/1% agarose gels and transblotted to Biotrans nylon membranes. The blots were hybridized with a 32P-end-labeled 35-mer oligonucleotide probe. The probe was complementary to nucleotides 257-291 of published cDNA sequence for MCP-1 (20) . The sequence of the probe was 5'-CGG-ATG-TTG-GGT-TTG-CTT-GTC-CAG-GTG-GTC-CAT-GG-3'. Hybridization was done overnight at 57°C in a solution containing 0.75 M NaCl, 0.15 M Tris-HCl (pH 8.0), 10 mM EDTA, 5x Denhardt's solution (1x Denhardt's solution: 0.02% bovine serum albumin/ 0.02% Ficoll/0.02% polyvinylpyrolidone), 0.1% SDS, 0.1% sodium pyrophosphate, 50 ,ug of heat-denatured, sheared, salmon sperm DNA per ml, and 2 x 106 cpm of probe per ml. Blots were washed twice with 20 ml of 0.2x SSC (lx SSC: 0.15 M NaCl/15 mM sodium citrate)/O. 1% SDS at 57°C for 30 sec, washed twice with 500 ml of the same solution at 57°C for 30 min, dried, and exposed between 16 and 64 hr (within the linear range of the film) to Kodak XAR-5 film with an intensifying screen at -70°C. The autoradiographs were scanned on an LKB Ultrascan laser densitometer and quantitated with the GELSCAN ii program for the Apple II computer.
Monocyte Transmigration Assay. To determine the effect of MM-LDL on monocyte transmigration into the subendothelial space of the cocultures, these preparations were washed, serum content of the medium was reduced to 2.5%, and the cocultures received 20 ,g/ml of MM-LDL, MM-LDL plus anti-SMCF Fab fragments, or MM-LDL plus irrelevant Fab fragments. These Fab fragments were prepared as described (21) . fMLP at a concentration of 0.1 ,uM was added to some of the cocultures as a reference chemoattractant. Human monocytes isolated as described above were labeled with the fluorescent compound ,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate (DiI) by incubating at 40C for 10 min (22) . The labeling of monocytes did not affect the monocyte adhesion or transmigration (data not shown). Following a 24-hr treatment of the cocultures with MM-LDL, Dil-labeled monocytes were added to the endothelial side of the preparations and were incubated at 370C for 60 min. The nonadherent or loosely attached monocytes were washed and removed, and then the preparations were fixed. The number of subendothelial monocytes in each preparation was determined in nine high-power fields under oil immersion.
RESULTS
As shown in Fig. 1A , anti-SMCF completely inhibited the chemotactic activity produced by human aortic EC and SMC in culture but did not inhibit the chemotaxis induced by fMLP. Moreover, the antibody completely inhibited the chemotactic activity in the medium from the glioma cell line U-1O5MG. Fig. 1B shows that MM-LDL itself was not chemotactic (condition C); however, MM-LDL increased the amount of chemotactic activity produced by EC and SMC approximately 2-to 3-fold but did not increase the chemotactic activity produced by the glioma cells. Anti-SMCF completely inhibited the chemotactic activity produced by the MM-LDL-stimulated cells.
Immunoprecipitation of the medium from [35S]methioninelabeled, unstimulated EC with anti-SMCF resulted in the presence of several protein bands on acrylamide gels. Two of these (10 kDa and 12.5 kDa) appeared to be specifically recognized by the antibody since they were not precipitated by irrelevant antibody, and their precipitation by anti-SMCF was completely inhibited by the addition of highly purified unlabeled SMCF (Fig. 2A) . Immunoprecipitation of equal trichloroacetic acid-precipitable cpm taken from the medium of MM-LDL-stimulated cells showed an increase in the incorporation of label into these protein species (Fig. 2B) , suggesting an increased biosynthesis and secretion in response to the MM-LDL. The increase was estimated to be 7-to 10-fold as determined by laser densitometric scanning. The increase in monocyte chemotactic activity in the medium from the MM-LDL-treated cells in this experiment was also 7-to 10-fold (data not shown).
Based on the published cDNA sequence for MCP-1 from the U-105MG glioma cells (20, 23) , we constructed a 35-mer oligonucleotide probe that was used for Northern blot analysis. Fig. 3A shows that human aortic EC, SMC, and the U-105MG glioma cells all constitutively expressed MCP-1 mRNA ('0.8 kilobase). The levels of MCP-1 mRNA (but not a-tubulin mRNA) increased in human aortic EC and SMC but not in the U-105MG cells after an 18-hr exposure to 20 pAg of MM-LDL per ml. Laser densitometry of the Northern blot autoradiograph (Fig. 3B) showed that the levels of MCP-1 mRNA were increased =22-fold in EC cells and 8-fold in SMC. Fig. 4 shows that MCP-1 message (but not a-tubulin mRNA) was increased by a 16-hr exposure to MM-LDL in a concentration-dependent manner. The absolute increase in MCP-1 message caused by a given concentration of MM-LDL varied with different MM-LDL preparations. However, a concentration-dependent relationship was maintained in all cases, with a plateau in MCP-1 mRNA expression seen with concentrations of MM-LDL between 20 and 30 ,g/ml.
The time-dependent induction of MCP-1 mRNA by 20 ,ug of MM-LDL per ml is shown in Fig. 5 . EC and SMC showed large increases in MCP-1 mRNA after a 4-hr exposure to MM-LDL. The laser densitometer scans clearly demonstrate that the time-dependent induction of MCP-1 mRNA was different in the two cell types. EC exhibited a rapid and protracted increase in MCP-1 mRNA, with the highest levels seen after a 20-hr exposure to MM-LDL. However, MCP-1 mRNA expression by MM-LDL-treated SMC reached a peak at 4 hr and declined to nearly constitutive levels after 20 hr. The ability of MM-LDL to stimulate monocyte chemotactic activity produced by human aortic EC and SMC in coculture separated by a thin layer of collagen is shown in Fig. 6 . MM-LDL induced monocyte migration into the subendothelial space of the coculture to the same degree as that induced by fMLP. The increased monocyte migration induced by MM-LDL (but not that induced by fMLP; data not shown) was completely inhibited by anti-SMCF Fab fragments but not by Fab fragments of an irrelevant antibody (Fig. 6) . Since it is known that EC produce M-CSF, which can induce monocyte migration (24) , and MM-LDL induces M-CSF mRNA (14) , the effect of anti-M-CSF Fab fragments on the chemotactic activity was also tested. However, unlike anti-SMCF Fab fragments, anti-M-CSF Fab fragments had no significant effect on monocyte migration into the subendothelial space of the cocultures (data not shown).
DISCUSSION
A number of monocyte chemotactic factors have been described that may be produced by EC and SMC, including collagen fragments (25) , elastin fragments (26) , fibronectin fragments (27) , transforming growth factor /3(28), and 8-kDa to 15-kDa proteins (5, 10, 23) .
We have shown here that all of the monocyte chemotactic activity released constitutively into the medium by adult human aortic EC and SMC as well as all of the MM-LDL-induced increase in chemotactic activity was attributable to MCP-1. Anti-SMCF completely inhibited the chemotactic activity produced by either MM-LDL-stimulated or unstimulated EC and SMC as well as the activity released constitutively from the glioma U-1O5MG cell line, from which MCP-1 was originally isolated. Anti-SMCF also completely inhibited the MM-LDL-induced monocyte migration into the subendothelial space of a coculture of human aortic wall cells. Furthermore, a 35-mer oligonucleotide probe, which was complementary to the published cDNA sequence of MCP-1 (20, 23) , specifically hybridized to the same size message in all three cell types and was shown to be dramatically increased in EC and SMC that were treated with MM-LDL. Thus the MM-LDL-stimulated increase in chemotactic activity correlated with the MM-LDL-stimulated increase in MCP-1 message.
Several proteins were immunoprecipitated from EC conditioned medium by anti-SMCF. However, only 10-kDa and 12.5-kDa proteins were increased in stimulated cells and were competitively inhibited by highly purified baboon SMCF. These proteins are similar in size to the monocyte chemotactic proteins isolated from human glioma U-1O5MG cells (13 kDa and 15 kDa) by Yoshimura and colleagues (17) , from the human osteosarcoma MG-63 cell line (9 kDa and 14 kDa), and from baboon SMC (14.4 kDa) by Graves and colleagues (9) . Yoshimura and colleagues found the amino acid compositions of the two peptides isolated from the glioma U-1O5MG cells to be indistinguishable (11) . The size differences may be due to cell-and species-specific posttranslational modifications, such as phosphorylation, glycosylation, or degradation. Therefore, we conclude that (i) SMCF is in fact MCP-1 and (it) MCP-1 is induced by MM-LDL.
Oxidized lipoproteins have been seen in atherosclerotic plaques (29) (30) (31) (32) (33) . A number of laboratories have studied LDL that has been modified to the extent that it is no longer LDL has contained 10-50 nmol of thiobarbituric acidreactive substances as malondialdehyde equivalents per mg of LDL cholesterol. However, such an extensive modification of LDL seems less likely at the very beginning of lesion formation because at this time there would be relatively few cells in the subendothelial space. In contrast to the highly oxidized LDL, MM-LDL contains only 2-5 nmol of thiobarbituric acid-reactive substances per mg of cholesterol (13, 40) and is taken up by the LDL receptor (13) . MM-LDL, therefore, may be physiologically more relevant in the initial stages of atherogenesis than its highly oxidized counterpart. Although MM-LDL itself is not chemotactic (in contrast to highly oxidized LDL; see ref. 6 ), this study demonstrates that MM-LDL is a potent inducer of MCP-1 in aortic EC and SMC whether cultured independently or together in coculture. Therefore, MM-LDL may be important in the monocyte recruitment into the subendothelium that is seen in the initial stages of atherogenesis.
